Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.
Fiche publication
Date publication
août 2017
Journal
Neuroendocrinology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier, Pr CADIOT Guillaume
Tous les auteurs :
de Mestier L, Cros J, Neuzillet C, Hentic O, Egal A, Muller N, Bouché O, Cadiot G, Ruszniewski P, Couvelard A, Hammel P
Lien Pubmed
Résumé
Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) are a heterogeneous subgroup of rare neoplasms that represent about a third of all poorly differentiated neuroendocrine carcinomas (PDNEC). MiNEN combine a neuroendocrine component, usually a PDNEC, and a non-neuroendocrine component, generally an adenocarcinoma, both accounting for at least 30% of the neoplasm. MiNEN are classified as high-, intermediate-, or low-grade malignancies depending on the metastatic potential of the tumour components. High-grade malignant component should be considered even if it represents <30% of the tumour. The prognosis of MiNEN is generally intermediate between those of the two "pure" components composing it. The aim of this comprehensive review of the literature is to suggest a standardized management of MiNEN. An increasing body of evidence suggests that PDNEC components share molecular abnormalities with their adenocarcinoma counterparts, but also display additional alterations. This advocates for a common origin, and that the presence of a PDNEC component in an adenocarcinoma could indicate a turning point in carcinogenesis.
Mots clés
Adenocarcinoma, Chemotherapy, Epidemiology, Mixed tumours, Neuroendocrine tumours, Prognosis, Treatment
Référence
Neuroendocrinology. 2017 Aug;: